Skip to main content
. 2019 Aug 22;5:14. doi: 10.1186/s40959-019-0046-5

Table 5.

Cardiotoxicity treatment: pre-and-post 2012 ESMO Guidelines [26]

Date of cardiotoxicity diagnosis 1994–2011
(n = 14)a
2012–2015
(n = 31)a
Change P value
Referred to cardiologist (pre-chemotherapy) 0 (0%) 7 (37%) ↑ 37% 0.060
Referred to cardiologist (any) 8 (57%) 19 (61%) ↑ 4% 0.793
Baseline ECHO undertaken 8 (57%) 23 (72%) ↑ 15% 0.253
Died during study period 6 (43%) 10 (32%) ↓ 11% 0.492

a Values and Percentages based on 45 of the 46 cases reviewed due data unavailability